<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVJI" lang="spa" raw_text_char_length="1634" raw_text_md5="17bd497c69fecf10d3d8fe8c9ceb629e" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="52" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Prueban mexicanos tratamiento eficaz contra Covid-19</ORIGINAL_TEXT>
<TOKEN end_char="7" id="token-0-0" morph="none" pos="word" start_char="1">Prueban</TOKEN>
<TOKEN end_char="17" id="token-0-1" morph="none" pos="word" start_char="9">mexicanos</TOKEN>
<TOKEN end_char="29" id="token-0-2" morph="none" pos="word" start_char="19">tratamiento</TOKEN>
<TOKEN end_char="36" id="token-0-3" morph="none" pos="word" start_char="31">eficaz</TOKEN>
<TOKEN end_char="43" id="token-0-4" morph="none" pos="word" start_char="38">contra</TOKEN>
<TOKEN end_char="52" id="token-0-5" morph="none" pos="unknown" start_char="45">Covid-19</TOKEN>
<TRANSLATED_TEXT>Testing Mexican effective treatment against Covid-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="170" id="segment-1" start_char="56">
<ORIGINAL_TEXT>Los resultados del estudio piloto fueron publicados el 3 de diciembre de 2020 en el "Journal of Internal Medicine".</ORIGINAL_TEXT>
<TOKEN end_char="58" id="token-1-0" morph="none" pos="word" start_char="56">Los</TOKEN>
<TOKEN end_char="69" id="token-1-1" morph="none" pos="word" start_char="60">resultados</TOKEN>
<TOKEN end_char="73" id="token-1-2" morph="none" pos="word" start_char="71">del</TOKEN>
<TOKEN end_char="81" id="token-1-3" morph="none" pos="word" start_char="75">estudio</TOKEN>
<TOKEN end_char="88" id="token-1-4" morph="none" pos="word" start_char="83">piloto</TOKEN>
<TOKEN end_char="95" id="token-1-5" morph="none" pos="word" start_char="90">fueron</TOKEN>
<TOKEN end_char="106" id="token-1-6" morph="none" pos="word" start_char="97">publicados</TOKEN>
<TOKEN end_char="109" id="token-1-7" morph="none" pos="word" start_char="108">el</TOKEN>
<TOKEN end_char="111" id="token-1-8" morph="none" pos="word" start_char="111">3</TOKEN>
<TOKEN end_char="114" id="token-1-9" morph="none" pos="word" start_char="113">de</TOKEN>
<TOKEN end_char="124" id="token-1-10" morph="none" pos="word" start_char="116">diciembre</TOKEN>
<TOKEN end_char="127" id="token-1-11" morph="none" pos="word" start_char="126">de</TOKEN>
<TOKEN end_char="132" id="token-1-12" morph="none" pos="word" start_char="129">2020</TOKEN>
<TOKEN end_char="135" id="token-1-13" morph="none" pos="word" start_char="134">en</TOKEN>
<TOKEN end_char="138" id="token-1-14" morph="none" pos="word" start_char="137">el</TOKEN>
<TOKEN end_char="140" id="token-1-15" morph="none" pos="punct" start_char="140">"</TOKEN>
<TOKEN end_char="147" id="token-1-16" morph="none" pos="word" start_char="141">Journal</TOKEN>
<TOKEN end_char="150" id="token-1-17" morph="none" pos="word" start_char="149">of</TOKEN>
<TOKEN end_char="159" id="token-1-18" morph="none" pos="word" start_char="152">Internal</TOKEN>
<TOKEN end_char="168" id="token-1-19" morph="none" pos="word" start_char="161">Medicine</TOKEN>
<TOKEN end_char="170" id="token-1-20" morph="none" pos="punct" start_char="169">".</TOKEN>
<TRANSLATED_TEXT>The results of the pilot study were published on December 3, 2020 in the Journal of Internal Medicine.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="185" id="segment-2" start_char="172">
<ORIGINAL_TEXT>[Foto: Achivo]</ORIGINAL_TEXT>
<TOKEN end_char="172" id="token-2-0" morph="none" pos="punct" start_char="172">[</TOKEN>
<TOKEN end_char="176" id="token-2-1" morph="none" pos="word" start_char="173">Foto</TOKEN>
<TOKEN end_char="177" id="token-2-2" morph="none" pos="punct" start_char="177">:</TOKEN>
<TOKEN end_char="184" id="token-2-3" morph="none" pos="word" start_char="179">Achivo</TOKEN>
<TOKEN end_char="185" id="token-2-4" morph="none" pos="punct" start_char="185">]</TOKEN>
<TRANSLATED_TEXT>[Picture: Achivo]</TRANSLATED_TEXT><DETECTED_LANGUAGE>it</DETECTED_LANGUAGE></SEG>
<SEG end_char="395" id="segment-3" start_char="189">
<ORIGINAL_TEXT>CIUDAD DE MÉXICO.- Médicos mexicanos demostraron la eficacia de un tratamiento de ciclosporinas A (CsA) con esteroides para reducir la mortalidad por Covid 19 en pacientes con enfermedad de moderada a grave.</ORIGINAL_TEXT>
<TOKEN end_char="194" id="token-3-0" morph="none" pos="word" start_char="189">CIUDAD</TOKEN>
<TOKEN end_char="197" id="token-3-1" morph="none" pos="word" start_char="196">DE</TOKEN>
<TOKEN end_char="204" id="token-3-2" morph="none" pos="word" start_char="199">MÉXICO</TOKEN>
<TOKEN end_char="206" id="token-3-3" morph="none" pos="punct" start_char="205">.-</TOKEN>
<TOKEN end_char="214" id="token-3-4" morph="none" pos="word" start_char="208">Médicos</TOKEN>
<TOKEN end_char="224" id="token-3-5" morph="none" pos="word" start_char="216">mexicanos</TOKEN>
<TOKEN end_char="236" id="token-3-6" morph="none" pos="word" start_char="226">demostraron</TOKEN>
<TOKEN end_char="239" id="token-3-7" morph="none" pos="word" start_char="238">la</TOKEN>
<TOKEN end_char="248" id="token-3-8" morph="none" pos="word" start_char="241">eficacia</TOKEN>
<TOKEN end_char="251" id="token-3-9" morph="none" pos="word" start_char="250">de</TOKEN>
<TOKEN end_char="254" id="token-3-10" morph="none" pos="word" start_char="253">un</TOKEN>
<TOKEN end_char="266" id="token-3-11" morph="none" pos="word" start_char="256">tratamiento</TOKEN>
<TOKEN end_char="269" id="token-3-12" morph="none" pos="word" start_char="268">de</TOKEN>
<TOKEN end_char="283" id="token-3-13" morph="none" pos="word" start_char="271">ciclosporinas</TOKEN>
<TOKEN end_char="285" id="token-3-14" morph="none" pos="word" start_char="285">A</TOKEN>
<TOKEN end_char="287" id="token-3-15" morph="none" pos="punct" start_char="287">(</TOKEN>
<TOKEN end_char="290" id="token-3-16" morph="none" pos="word" start_char="288">CsA</TOKEN>
<TOKEN end_char="291" id="token-3-17" morph="none" pos="punct" start_char="291">)</TOKEN>
<TOKEN end_char="295" id="token-3-18" morph="none" pos="word" start_char="293">con</TOKEN>
<TOKEN end_char="306" id="token-3-19" morph="none" pos="word" start_char="297">esteroides</TOKEN>
<TOKEN end_char="311" id="token-3-20" morph="none" pos="word" start_char="308">para</TOKEN>
<TOKEN end_char="319" id="token-3-21" morph="none" pos="word" start_char="313">reducir</TOKEN>
<TOKEN end_char="322" id="token-3-22" morph="none" pos="word" start_char="321">la</TOKEN>
<TOKEN end_char="333" id="token-3-23" morph="none" pos="word" start_char="324">mortalidad</TOKEN>
<TOKEN end_char="337" id="token-3-24" morph="none" pos="word" start_char="335">por</TOKEN>
<TOKEN end_char="343" id="token-3-25" morph="none" pos="word" start_char="339">Covid</TOKEN>
<TOKEN end_char="346" id="token-3-26" morph="none" pos="word" start_char="345">19</TOKEN>
<TOKEN end_char="349" id="token-3-27" morph="none" pos="word" start_char="348">en</TOKEN>
<TOKEN end_char="359" id="token-3-28" morph="none" pos="word" start_char="351">pacientes</TOKEN>
<TOKEN end_char="363" id="token-3-29" morph="none" pos="word" start_char="361">con</TOKEN>
<TOKEN end_char="374" id="token-3-30" morph="none" pos="word" start_char="365">enfermedad</TOKEN>
<TOKEN end_char="377" id="token-3-31" morph="none" pos="word" start_char="376">de</TOKEN>
<TOKEN end_char="386" id="token-3-32" morph="none" pos="word" start_char="379">moderada</TOKEN>
<TOKEN end_char="388" id="token-3-33" morph="none" pos="word" start_char="388">a</TOKEN>
<TOKEN end_char="394" id="token-3-34" morph="none" pos="word" start_char="390">grave</TOKEN>
<TOKEN end_char="395" id="token-3-35" morph="none" pos="punct" start_char="395">.</TOKEN>
<TRANSLATED_TEXT>MEXICO CITY - Mexican doctors demonstrated the effectiveness of steroid ciclosporin A (CsA) treatment to reduce mortality from Covid 19 in patients with moderate to severe disease.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="546" id="segment-4" start_char="398">
<ORIGINAL_TEXT>En el estudio piloto participaron 209 pacientes enfermos de SARS-CoV-2 hospitalizados entre abril y mayo de 2020 en un hospital del ISSSTE en Puebla.</ORIGINAL_TEXT>
<TOKEN end_char="399" id="token-4-0" morph="none" pos="word" start_char="398">En</TOKEN>
<TOKEN end_char="402" id="token-4-1" morph="none" pos="word" start_char="401">el</TOKEN>
<TOKEN end_char="410" id="token-4-2" morph="none" pos="word" start_char="404">estudio</TOKEN>
<TOKEN end_char="417" id="token-4-3" morph="none" pos="word" start_char="412">piloto</TOKEN>
<TOKEN end_char="430" id="token-4-4" morph="none" pos="word" start_char="419">participaron</TOKEN>
<TOKEN end_char="434" id="token-4-5" morph="none" pos="word" start_char="432">209</TOKEN>
<TOKEN end_char="444" id="token-4-6" morph="none" pos="word" start_char="436">pacientes</TOKEN>
<TOKEN end_char="453" id="token-4-7" morph="none" pos="word" start_char="446">enfermos</TOKEN>
<TOKEN end_char="456" id="token-4-8" morph="none" pos="word" start_char="455">de</TOKEN>
<TOKEN end_char="467" id="token-4-9" morph="none" pos="unknown" start_char="458">SARS-CoV-2</TOKEN>
<TOKEN end_char="482" id="token-4-10" morph="none" pos="word" start_char="469">hospitalizados</TOKEN>
<TOKEN end_char="488" id="token-4-11" morph="none" pos="word" start_char="484">entre</TOKEN>
<TOKEN end_char="494" id="token-4-12" morph="none" pos="word" start_char="490">abril</TOKEN>
<TOKEN end_char="496" id="token-4-13" morph="none" pos="word" start_char="496">y</TOKEN>
<TOKEN end_char="501" id="token-4-14" morph="none" pos="word" start_char="498">mayo</TOKEN>
<TOKEN end_char="504" id="token-4-15" morph="none" pos="word" start_char="503">de</TOKEN>
<TOKEN end_char="509" id="token-4-16" morph="none" pos="word" start_char="506">2020</TOKEN>
<TOKEN end_char="512" id="token-4-17" morph="none" pos="word" start_char="511">en</TOKEN>
<TOKEN end_char="515" id="token-4-18" morph="none" pos="word" start_char="514">un</TOKEN>
<TOKEN end_char="524" id="token-4-19" morph="none" pos="word" start_char="517">hospital</TOKEN>
<TOKEN end_char="528" id="token-4-20" morph="none" pos="word" start_char="526">del</TOKEN>
<TOKEN end_char="535" id="token-4-21" morph="none" pos="word" start_char="530">ISSSTE</TOKEN>
<TOKEN end_char="538" id="token-4-22" morph="none" pos="word" start_char="537">en</TOKEN>
<TOKEN end_char="545" id="token-4-23" morph="none" pos="word" start_char="540">Puebla</TOKEN>
<TOKEN end_char="546" id="token-4-24" morph="none" pos="punct" start_char="546">.</TOKEN>
<TRANSLATED_TEXT>The pilot study involved 209 patients with SARS-CoV-2 who were hospitalized between April and May 2020 at an ISSSTE hospital in Puebla.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="900" id="segment-5" start_char="549">
<ORIGINAL_TEXT>La conclusión es que la ciclosporina A, utilizada como coadyuvante al tratamiento de esteroides (metilprednisolona o prednisona) en pacientes con Covid-19, demostró tener mejores resultados respecto a los pacientes tratados sólo con esteroides, con una significativa reducción de la mortalidad, en especial en aquellos con neumonía de moderada a grave.</ORIGINAL_TEXT>
<TOKEN end_char="550" id="token-5-0" morph="none" pos="word" start_char="549">La</TOKEN>
<TOKEN end_char="561" id="token-5-1" morph="none" pos="word" start_char="552">conclusión</TOKEN>
<TOKEN end_char="564" id="token-5-2" morph="none" pos="word" start_char="563">es</TOKEN>
<TOKEN end_char="568" id="token-5-3" morph="none" pos="word" start_char="566">que</TOKEN>
<TOKEN end_char="571" id="token-5-4" morph="none" pos="word" start_char="570">la</TOKEN>
<TOKEN end_char="584" id="token-5-5" morph="none" pos="word" start_char="573">ciclosporina</TOKEN>
<TOKEN end_char="586" id="token-5-6" morph="none" pos="word" start_char="586">A</TOKEN>
<TOKEN end_char="587" id="token-5-7" morph="none" pos="punct" start_char="587">,</TOKEN>
<TOKEN end_char="597" id="token-5-8" morph="none" pos="word" start_char="589">utilizada</TOKEN>
<TOKEN end_char="602" id="token-5-9" morph="none" pos="word" start_char="599">como</TOKEN>
<TOKEN end_char="614" id="token-5-10" morph="none" pos="word" start_char="604">coadyuvante</TOKEN>
<TOKEN end_char="617" id="token-5-11" morph="none" pos="word" start_char="616">al</TOKEN>
<TOKEN end_char="629" id="token-5-12" morph="none" pos="word" start_char="619">tratamiento</TOKEN>
<TOKEN end_char="632" id="token-5-13" morph="none" pos="word" start_char="631">de</TOKEN>
<TOKEN end_char="643" id="token-5-14" morph="none" pos="word" start_char="634">esteroides</TOKEN>
<TOKEN end_char="645" id="token-5-15" morph="none" pos="punct" start_char="645">(</TOKEN>
<TOKEN end_char="662" id="token-5-16" morph="none" pos="word" start_char="646">metilprednisolona</TOKEN>
<TOKEN end_char="664" id="token-5-17" morph="none" pos="word" start_char="664">o</TOKEN>
<TOKEN end_char="675" id="token-5-18" morph="none" pos="word" start_char="666">prednisona</TOKEN>
<TOKEN end_char="676" id="token-5-19" morph="none" pos="punct" start_char="676">)</TOKEN>
<TOKEN end_char="679" id="token-5-20" morph="none" pos="word" start_char="678">en</TOKEN>
<TOKEN end_char="689" id="token-5-21" morph="none" pos="word" start_char="681">pacientes</TOKEN>
<TOKEN end_char="693" id="token-5-22" morph="none" pos="word" start_char="691">con</TOKEN>
<TOKEN end_char="702" id="token-5-23" morph="none" pos="unknown" start_char="695">Covid-19</TOKEN>
<TOKEN end_char="703" id="token-5-24" morph="none" pos="punct" start_char="703">,</TOKEN>
<TOKEN end_char="712" id="token-5-25" morph="none" pos="word" start_char="705">demostró</TOKEN>
<TOKEN end_char="718" id="token-5-26" morph="none" pos="word" start_char="714">tener</TOKEN>
<TOKEN end_char="726" id="token-5-27" morph="none" pos="word" start_char="720">mejores</TOKEN>
<TOKEN end_char="737" id="token-5-28" morph="none" pos="word" start_char="728">resultados</TOKEN>
<TOKEN end_char="746" id="token-5-29" morph="none" pos="word" start_char="739">respecto</TOKEN>
<TOKEN end_char="748" id="token-5-30" morph="none" pos="word" start_char="748">a</TOKEN>
<TOKEN end_char="752" id="token-5-31" morph="none" pos="word" start_char="750">los</TOKEN>
<TOKEN end_char="762" id="token-5-32" morph="none" pos="word" start_char="754">pacientes</TOKEN>
<TOKEN end_char="771" id="token-5-33" morph="none" pos="word" start_char="764">tratados</TOKEN>
<TOKEN end_char="776" id="token-5-34" morph="none" pos="word" start_char="773">sólo</TOKEN>
<TOKEN end_char="780" id="token-5-35" morph="none" pos="word" start_char="778">con</TOKEN>
<TOKEN end_char="791" id="token-5-36" morph="none" pos="word" start_char="782">esteroides</TOKEN>
<TOKEN end_char="792" id="token-5-37" morph="none" pos="punct" start_char="792">,</TOKEN>
<TOKEN end_char="796" id="token-5-38" morph="none" pos="word" start_char="794">con</TOKEN>
<TOKEN end_char="800" id="token-5-39" morph="none" pos="word" start_char="798">una</TOKEN>
<TOKEN end_char="814" id="token-5-40" morph="none" pos="word" start_char="802">significativa</TOKEN>
<TOKEN end_char="824" id="token-5-41" morph="none" pos="word" start_char="816">reducción</TOKEN>
<TOKEN end_char="827" id="token-5-42" morph="none" pos="word" start_char="826">de</TOKEN>
<TOKEN end_char="830" id="token-5-43" morph="none" pos="word" start_char="829">la</TOKEN>
<TOKEN end_char="841" id="token-5-44" morph="none" pos="word" start_char="832">mortalidad</TOKEN>
<TOKEN end_char="842" id="token-5-45" morph="none" pos="punct" start_char="842">,</TOKEN>
<TOKEN end_char="845" id="token-5-46" morph="none" pos="word" start_char="844">en</TOKEN>
<TOKEN end_char="854" id="token-5-47" morph="none" pos="word" start_char="847">especial</TOKEN>
<TOKEN end_char="857" id="token-5-48" morph="none" pos="word" start_char="856">en</TOKEN>
<TOKEN end_char="866" id="token-5-49" morph="none" pos="word" start_char="859">aquellos</TOKEN>
<TOKEN end_char="870" id="token-5-50" morph="none" pos="word" start_char="868">con</TOKEN>
<TOKEN end_char="879" id="token-5-51" morph="none" pos="word" start_char="872">neumonía</TOKEN>
<TOKEN end_char="882" id="token-5-52" morph="none" pos="word" start_char="881">de</TOKEN>
<TOKEN end_char="891" id="token-5-53" morph="none" pos="word" start_char="884">moderada</TOKEN>
<TOKEN end_char="893" id="token-5-54" morph="none" pos="word" start_char="893">a</TOKEN>
<TOKEN end_char="899" id="token-5-55" morph="none" pos="word" start_char="895">grave</TOKEN>
<TOKEN end_char="900" id="token-5-56" morph="none" pos="punct" start_char="900">.</TOKEN>
<TRANSLATED_TEXT>The conclusion is that ciclosporin A, used as an adjuvant in the treatment of steroids (methylprednisolone or prednisone) in patients with Covid-19, has been shown to have better results than those treated only with steroids, with a significant reduction in mortality, especially in those with moderate to severe pneumonia.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1035" id="segment-6" start_char="903">
<ORIGINAL_TEXT>El estudio fue liderado por José Luis Gálvez Romero, médico internista e inmunoalergólogo del Hospital Regional del ISSSTE en Puebla.</ORIGINAL_TEXT>
<TOKEN end_char="904" id="token-6-0" morph="none" pos="word" start_char="903">El</TOKEN>
<TOKEN end_char="912" id="token-6-1" morph="none" pos="word" start_char="906">estudio</TOKEN>
<TOKEN end_char="916" id="token-6-2" morph="none" pos="word" start_char="914">fue</TOKEN>
<TOKEN end_char="925" id="token-6-3" morph="none" pos="word" start_char="918">liderado</TOKEN>
<TOKEN end_char="929" id="token-6-4" morph="none" pos="word" start_char="927">por</TOKEN>
<TOKEN end_char="934" id="token-6-5" morph="none" pos="word" start_char="931">José</TOKEN>
<TOKEN end_char="939" id="token-6-6" morph="none" pos="word" start_char="936">Luis</TOKEN>
<TOKEN end_char="946" id="token-6-7" morph="none" pos="word" start_char="941">Gálvez</TOKEN>
<TOKEN end_char="953" id="token-6-8" morph="none" pos="word" start_char="948">Romero</TOKEN>
<TOKEN end_char="954" id="token-6-9" morph="none" pos="punct" start_char="954">,</TOKEN>
<TOKEN end_char="961" id="token-6-10" morph="none" pos="word" start_char="956">médico</TOKEN>
<TOKEN end_char="972" id="token-6-11" morph="none" pos="word" start_char="963">internista</TOKEN>
<TOKEN end_char="974" id="token-6-12" morph="none" pos="word" start_char="974">e</TOKEN>
<TOKEN end_char="991" id="token-6-13" morph="none" pos="word" start_char="976">inmunoalergólogo</TOKEN>
<TOKEN end_char="995" id="token-6-14" morph="none" pos="word" start_char="993">del</TOKEN>
<TOKEN end_char="1004" id="token-6-15" morph="none" pos="word" start_char="997">Hospital</TOKEN>
<TOKEN end_char="1013" id="token-6-16" morph="none" pos="word" start_char="1006">Regional</TOKEN>
<TOKEN end_char="1017" id="token-6-17" morph="none" pos="word" start_char="1015">del</TOKEN>
<TOKEN end_char="1024" id="token-6-18" morph="none" pos="word" start_char="1019">ISSSTE</TOKEN>
<TOKEN end_char="1027" id="token-6-19" morph="none" pos="word" start_char="1026">en</TOKEN>
<TOKEN end_char="1034" id="token-6-20" morph="none" pos="word" start_char="1029">Puebla</TOKEN>
<TOKEN end_char="1035" id="token-6-21" morph="none" pos="punct" start_char="1035">.</TOKEN>
<TRANSLATED_TEXT>The study was led by José Luis Gálvez Romero, internist physician and immuno-allerologist of the ISSSTE Regional Hospital in Puebla.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1142" id="segment-7" start_char="1038">
<ORIGINAL_TEXT>Los investigadores apuntan la necesidad de realizar más investigaciones con ensayos clínicos controlados.</ORIGINAL_TEXT>
<TOKEN end_char="1040" id="token-7-0" morph="none" pos="word" start_char="1038">Los</TOKEN>
<TOKEN end_char="1055" id="token-7-1" morph="none" pos="word" start_char="1042">investigadores</TOKEN>
<TOKEN end_char="1063" id="token-7-2" morph="none" pos="word" start_char="1057">apuntan</TOKEN>
<TOKEN end_char="1066" id="token-7-3" morph="none" pos="word" start_char="1065">la</TOKEN>
<TOKEN end_char="1076" id="token-7-4" morph="none" pos="word" start_char="1068">necesidad</TOKEN>
<TOKEN end_char="1079" id="token-7-5" morph="none" pos="word" start_char="1078">de</TOKEN>
<TOKEN end_char="1088" id="token-7-6" morph="none" pos="word" start_char="1081">realizar</TOKEN>
<TOKEN end_char="1092" id="token-7-7" morph="none" pos="word" start_char="1090">más</TOKEN>
<TOKEN end_char="1108" id="token-7-8" morph="none" pos="word" start_char="1094">investigaciones</TOKEN>
<TOKEN end_char="1112" id="token-7-9" morph="none" pos="word" start_char="1110">con</TOKEN>
<TOKEN end_char="1120" id="token-7-10" morph="none" pos="word" start_char="1114">ensayos</TOKEN>
<TOKEN end_char="1129" id="token-7-11" morph="none" pos="word" start_char="1122">clínicos</TOKEN>
<TOKEN end_char="1141" id="token-7-12" morph="none" pos="word" start_char="1131">controlados</TOKEN>
<TOKEN end_char="1142" id="token-7-13" morph="none" pos="punct" start_char="1142">.</TOKEN>
<TRANSLATED_TEXT>Researchers point to the need for more research with controlled clinical trials.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1515" id="segment-8" start_char="1145">
<ORIGINAL_TEXT>"Frente a la falta de tratamientos eficaces para el Covid-19 y la crisis de salud pública provocaba por la pandemia, creemos que estas observaciones justifican una investigación más profunda mediante ensayos clínicos controlados para determinar la eficacia de la adición de CsA al tratamiento de pacientes con infección por SARS-CoV-2", concluyen los autores del estudio.</ORIGINAL_TEXT>
<TOKEN end_char="1145" id="token-8-0" morph="none" pos="punct" start_char="1145">"</TOKEN>
<TOKEN end_char="1151" id="token-8-1" morph="none" pos="word" start_char="1146">Frente</TOKEN>
<TOKEN end_char="1153" id="token-8-2" morph="none" pos="word" start_char="1153">a</TOKEN>
<TOKEN end_char="1156" id="token-8-3" morph="none" pos="word" start_char="1155">la</TOKEN>
<TOKEN end_char="1162" id="token-8-4" morph="none" pos="word" start_char="1158">falta</TOKEN>
<TOKEN end_char="1165" id="token-8-5" morph="none" pos="word" start_char="1164">de</TOKEN>
<TOKEN end_char="1178" id="token-8-6" morph="none" pos="word" start_char="1167">tratamientos</TOKEN>
<TOKEN end_char="1187" id="token-8-7" morph="none" pos="word" start_char="1180">eficaces</TOKEN>
<TOKEN end_char="1192" id="token-8-8" morph="none" pos="word" start_char="1189">para</TOKEN>
<TOKEN end_char="1195" id="token-8-9" morph="none" pos="word" start_char="1194">el</TOKEN>
<TOKEN end_char="1204" id="token-8-10" morph="none" pos="unknown" start_char="1197">Covid-19</TOKEN>
<TOKEN end_char="1206" id="token-8-11" morph="none" pos="word" start_char="1206">y</TOKEN>
<TOKEN end_char="1209" id="token-8-12" morph="none" pos="word" start_char="1208">la</TOKEN>
<TOKEN end_char="1216" id="token-8-13" morph="none" pos="word" start_char="1211">crisis</TOKEN>
<TOKEN end_char="1219" id="token-8-14" morph="none" pos="word" start_char="1218">de</TOKEN>
<TOKEN end_char="1225" id="token-8-15" morph="none" pos="word" start_char="1221">salud</TOKEN>
<TOKEN end_char="1233" id="token-8-16" morph="none" pos="word" start_char="1227">pública</TOKEN>
<TOKEN end_char="1243" id="token-8-17" morph="none" pos="word" start_char="1235">provocaba</TOKEN>
<TOKEN end_char="1247" id="token-8-18" morph="none" pos="word" start_char="1245">por</TOKEN>
<TOKEN end_char="1250" id="token-8-19" morph="none" pos="word" start_char="1249">la</TOKEN>
<TOKEN end_char="1259" id="token-8-20" morph="none" pos="word" start_char="1252">pandemia</TOKEN>
<TOKEN end_char="1260" id="token-8-21" morph="none" pos="punct" start_char="1260">,</TOKEN>
<TOKEN end_char="1268" id="token-8-22" morph="none" pos="word" start_char="1262">creemos</TOKEN>
<TOKEN end_char="1272" id="token-8-23" morph="none" pos="word" start_char="1270">que</TOKEN>
<TOKEN end_char="1278" id="token-8-24" morph="none" pos="word" start_char="1274">estas</TOKEN>
<TOKEN end_char="1292" id="token-8-25" morph="none" pos="word" start_char="1280">observaciones</TOKEN>
<TOKEN end_char="1303" id="token-8-26" morph="none" pos="word" start_char="1294">justifican</TOKEN>
<TOKEN end_char="1307" id="token-8-27" morph="none" pos="word" start_char="1305">una</TOKEN>
<TOKEN end_char="1321" id="token-8-28" morph="none" pos="word" start_char="1309">investigación</TOKEN>
<TOKEN end_char="1325" id="token-8-29" morph="none" pos="word" start_char="1323">más</TOKEN>
<TOKEN end_char="1334" id="token-8-30" morph="none" pos="word" start_char="1327">profunda</TOKEN>
<TOKEN end_char="1343" id="token-8-31" morph="none" pos="word" start_char="1336">mediante</TOKEN>
<TOKEN end_char="1351" id="token-8-32" morph="none" pos="word" start_char="1345">ensayos</TOKEN>
<TOKEN end_char="1360" id="token-8-33" morph="none" pos="word" start_char="1353">clínicos</TOKEN>
<TOKEN end_char="1372" id="token-8-34" morph="none" pos="word" start_char="1362">controlados</TOKEN>
<TOKEN end_char="1377" id="token-8-35" morph="none" pos="word" start_char="1374">para</TOKEN>
<TOKEN end_char="1388" id="token-8-36" morph="none" pos="word" start_char="1379">determinar</TOKEN>
<TOKEN end_char="1391" id="token-8-37" morph="none" pos="word" start_char="1390">la</TOKEN>
<TOKEN end_char="1400" id="token-8-38" morph="none" pos="word" start_char="1393">eficacia</TOKEN>
<TOKEN end_char="1403" id="token-8-39" morph="none" pos="word" start_char="1402">de</TOKEN>
<TOKEN end_char="1406" id="token-8-40" morph="none" pos="word" start_char="1405">la</TOKEN>
<TOKEN end_char="1414" id="token-8-41" morph="none" pos="word" start_char="1408">adición</TOKEN>
<TOKEN end_char="1417" id="token-8-42" morph="none" pos="word" start_char="1416">de</TOKEN>
<TOKEN end_char="1421" id="token-8-43" morph="none" pos="word" start_char="1419">CsA</TOKEN>
<TOKEN end_char="1424" id="token-8-44" morph="none" pos="word" start_char="1423">al</TOKEN>
<TOKEN end_char="1436" id="token-8-45" morph="none" pos="word" start_char="1426">tratamiento</TOKEN>
<TOKEN end_char="1439" id="token-8-46" morph="none" pos="word" start_char="1438">de</TOKEN>
<TOKEN end_char="1449" id="token-8-47" morph="none" pos="word" start_char="1441">pacientes</TOKEN>
<TOKEN end_char="1453" id="token-8-48" morph="none" pos="word" start_char="1451">con</TOKEN>
<TOKEN end_char="1463" id="token-8-49" morph="none" pos="word" start_char="1455">infección</TOKEN>
<TOKEN end_char="1467" id="token-8-50" morph="none" pos="word" start_char="1465">por</TOKEN>
<TOKEN end_char="1478" id="token-8-51" morph="none" pos="unknown" start_char="1469">SARS-CoV-2</TOKEN>
<TOKEN end_char="1480" id="token-8-52" morph="none" pos="punct" start_char="1479">",</TOKEN>
<TOKEN end_char="1490" id="token-8-53" morph="none" pos="word" start_char="1482">concluyen</TOKEN>
<TOKEN end_char="1494" id="token-8-54" morph="none" pos="word" start_char="1492">los</TOKEN>
<TOKEN end_char="1502" id="token-8-55" morph="none" pos="word" start_char="1496">autores</TOKEN>
<TOKEN end_char="1506" id="token-8-56" morph="none" pos="word" start_char="1504">del</TOKEN>
<TOKEN end_char="1514" id="token-8-57" morph="none" pos="word" start_char="1508">estudio</TOKEN>
<TOKEN end_char="1515" id="token-8-58" morph="none" pos="punct" start_char="1515">.</TOKEN>
<TRANSLATED_TEXT>"In view of the lack of effective treatments for Covid-19 and the public health crisis caused by the pandemic, we believe that these observations justify a deeper investigation through controlled clinical trials to determine the efficacy of the addition of CsA to the treatment of patients with SARS-CoV-2 infection," concluded the authors of the study.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1630" id="segment-9" start_char="1518">
<ORIGINAL_TEXT>Los resultados del estudio piloto fueron publicados el 3 de diciembre de 2020 en el Journal of Internal Medicine.</ORIGINAL_TEXT>
<TOKEN end_char="1520" id="token-9-0" morph="none" pos="word" start_char="1518">Los</TOKEN>
<TOKEN end_char="1531" id="token-9-1" morph="none" pos="word" start_char="1522">resultados</TOKEN>
<TOKEN end_char="1535" id="token-9-2" morph="none" pos="word" start_char="1533">del</TOKEN>
<TOKEN end_char="1543" id="token-9-3" morph="none" pos="word" start_char="1537">estudio</TOKEN>
<TOKEN end_char="1550" id="token-9-4" morph="none" pos="word" start_char="1545">piloto</TOKEN>
<TOKEN end_char="1557" id="token-9-5" morph="none" pos="word" start_char="1552">fueron</TOKEN>
<TOKEN end_char="1568" id="token-9-6" morph="none" pos="word" start_char="1559">publicados</TOKEN>
<TOKEN end_char="1571" id="token-9-7" morph="none" pos="word" start_char="1570">el</TOKEN>
<TOKEN end_char="1573" id="token-9-8" morph="none" pos="word" start_char="1573">3</TOKEN>
<TOKEN end_char="1576" id="token-9-9" morph="none" pos="word" start_char="1575">de</TOKEN>
<TOKEN end_char="1586" id="token-9-10" morph="none" pos="word" start_char="1578">diciembre</TOKEN>
<TOKEN end_char="1589" id="token-9-11" morph="none" pos="word" start_char="1588">de</TOKEN>
<TOKEN end_char="1594" id="token-9-12" morph="none" pos="word" start_char="1591">2020</TOKEN>
<TOKEN end_char="1597" id="token-9-13" morph="none" pos="word" start_char="1596">en</TOKEN>
<TOKEN end_char="1600" id="token-9-14" morph="none" pos="word" start_char="1599">el</TOKEN>
<TOKEN end_char="1608" id="token-9-15" morph="none" pos="word" start_char="1602">Journal</TOKEN>
<TOKEN end_char="1611" id="token-9-16" morph="none" pos="word" start_char="1610">of</TOKEN>
<TOKEN end_char="1620" id="token-9-17" morph="none" pos="word" start_char="1613">Internal</TOKEN>
<TOKEN end_char="1629" id="token-9-18" morph="none" pos="word" start_char="1622">Medicine</TOKEN>
<TOKEN end_char="1630" id="token-9-19" morph="none" pos="punct" start_char="1630">.</TOKEN>
<TRANSLATED_TEXT>The results of the pilot study were published on December 3, 2020 in the Journal of Internal Medicine.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>